PHG Stock Analysis: Buy, Sell, or Hold?
PHG - KONINKLIJKE PHILIPS N.V.
$27.34
-0.06 (-0.22%)
▼
5d:
-2.91%
30d:
+6.51%
90d:
-3.43%
BUY
HIGH Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 28, 2026
14d
Get Alerted When PHG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PHG shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: PHG shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$42.99
Based on 8.5% avg growth
INTRINSIC VALUE TODAY
$26.69
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHG is currently trading at $27.34, which is considered slightly high relative to its 30-day fair value range of $25.97 to $27.47. The stock's valuation (Forward PE: 13.6) is in line with its historical norms (14.2). Remarkably, the market is currently pricing in an annual earnings decline of 1.6% over the next few years. This pessimistic expectation contrasts with the company's recent 97.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PHG is in a downtrend. The price is currently testing key support at $26.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PHG has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.26 (+21.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PHG is in a downtrend. The price is currently testing key support at $26.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PHG has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.26 (+21.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$25.97 -
$27.47
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.4% below Wall St target ($33.26)
Trading Range Analysis
30-Day Trading Range
$25.97 -
$27.47
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$26.86
Resistance Level
$28.53
Current Trend
Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.55
Wall Street Target
$33.26
(+21.4%)
Revenue Growth (YoY)
-4.7%
Earnings Growth (YoY)
97.2%
Profit Margin
5.5%
Valuation Discount vs History
-1.6% cheaper
PE vs Historical
13.6 vs 14.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.6%
(market-implied from PE analysis)
1-Year Target
$26.96
(-2%)
2-Year Target
$26.53
(-3%)
3-Year Target
$26.11
(-5%)
3-Yr Target (if PE normalizes)
(PE: 14→14)
$27.36
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 12.9%)
$63.34
(+131%)
Base:
(SPY PE: 13.5, Growth: 12.9%)
$39.41
(+44%)
Bear:
(PE: 11.5, Growth: 12.9%)
$33.50
(+22%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 24.12 | Current EPS (TTM): $1.13
Bull Case
$53.66
(+96%)
Analyst growth 79.0%, PE expands to 26.5
Base Case
$48.78
(+78%)
Market implied 79.0%, PE stable at 24.1
Bear Case
$18.54
(-32%)
Severe decline -20.0%, PE contracts to 20.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.5 to 14.2
Stabilization Target:
$28.72
(+4.8%)
PE Expansion Potential:
+4.8%
Share & Embed Analysis
Last updated: July 13, 2026 4:21 PM ET
Data refreshes hourly during market hours. Next update: 5:21 PM
Data refreshes hourly during market hours. Next update: 5:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 67 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 57 HOLD |
